Pharma Industry News Weekly Recap: March 17, 2023

2023-03-17T09:37:56-07:004IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US March [...]

Pharma Industry News Weekly Recap: March 10, 2023

2023-03-10T10:50:08-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics With PCSK9 pill, Merck aims to succeed where others failed March 7, 2023 / [...]

Pharma Industry News Weekly Recap: March 3, 2023

2023-03-03T10:18:48-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year [...]

Pharma Industry News Weekly Recap: February 24, 2023

2023-02-24T12:31:09-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Eli Lilly's diabetes drug Mounjaro back in stock amid heightened obesity interest February [...]

Pharma Industry News Weekly Recap: February 17, 2023

2023-02-17T13:56:36-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Faced with safety issues over inflammation drug, AstraZeneca spinout Aristea closes shop February [...]

Pharma Industry News Weekly Recap: February 10, 2023

2023-02-10T07:38:24-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics AstraZeneca deals another blow to IL-12, dumping therapy to follow BMS, Merck KGaA out [...]

Pharma Industry News Weekly Recap: February 3, 2023

2023-02-03T09:38:58-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s [...]

Pharma Industry News Weekly Recap: January 27, 2023

2023-02-14T11:04:25-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics J&J puts focus on cancer drugs in push to reach 2025 sales target [...]

Pharma Industry News Weekly Recap: January 20, 2023

2023-02-07T14:04:31-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics AbbVie, Novartis and more win national coverage in China even as Pfizer's Paxlovid [...]

Pharma Industry News Weekly Recap: January 6, 2023

2023-02-07T14:13:36-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics Lilly, seeking better CNS gene therapies, pays $55M to join AbbVie on AAV [...]

Go to Top